{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:47:32Z","timestamp":1793141252888,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"science and research fund of Shanxi Health Commission","award":["2022043"],"award-info":[{"award-number":["2022043"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073090"],"award-info":[{"award-number":["82073090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Human Resources and Social Security Department System of Shanxi Province","award":["20210001"],"award-info":[{"award-number":["20210001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-024-09959-1","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T23:57:50Z","timestamp":1734739070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-\u03b2catenin\/Hippo pathway"],"prefix":"10.1007","volume":"41","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"13","key":"9959_CR1","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle H, Bauer A, Stappert J, et al. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16(13):3797\u2013804.","journal-title":"EMBO J"},{"issue":"3","key":"9959_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/thno.29271","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao J, Zhao M, Liu J, et al. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog. Theranostics. 2019;9(3):811\u201328.","journal-title":"Theranostics"},{"issue":"15","key":"9959_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/sj.onc.1201715","volume":"16","author":"DD Chang","year":"1998","unstructured":"Chang DD, Park NH, Denny CT, et al. Characterization of transformation related genes in oral cancer cells. Oncogene. 1998;16(15):1921\u201330.","journal-title":"Oncogene"},{"issue":"6","key":"9959_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254\u201370. https:\/\/doi.org\/10.1002\/hep.29683.","journal-title":"Hepatology"},{"issue":"3","key":"9959_CR5","doi-asserted-by":"publisher","first-page":"1015081","DOI":"10.1101\/cshperspect.a015081","volume":"5","author":"C-M Cruciat","year":"2013","unstructured":"Cruciat C-M, Niehrs C. Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb Perspect Biol. 2013;5(3):1015081.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7397","key":"9959_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201\u20136.","journal-title":"Nature"},{"key":"9959_CR7","doi-asserted-by":"crossref","unstructured":"Gong W, Zeng J, JI J, et al. EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance. Biomolecules. 2021;11(4).","DOI":"10.3390\/biom11040547"},{"key":"9959_CR8","doi-asserted-by":"publisher","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer.\u00a0Mol Cancer. 2019;18(1):176. Published 2019 Dec 4. https:\/\/doi.org\/10.1186\/s12943-019-1109-9","DOI":"10.1186\/s12943-019-1109-9"},{"key":"9959_CR9","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He S, Tang S. Wnt\/\u03b2-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"9959_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-017-0734-4","volume":"16","author":"X Huo","year":"2017","unstructured":"Huo X, Han S, Wu G, et al. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017;16(1):165.","journal-title":"Mol Cancer"},{"key":"9959_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1476-4598-7-71","volume":"7","author":"WG Jiang","year":"2008","unstructured":"Jiang WG, Martin TA, Lewis-Russell JM, et al. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer. 2008;7:71.","journal-title":"Mol Cancer"},{"issue":"45","key":"9959_CR12","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1038\/s41388-023-02849-6","volume":"42","author":"W Jiang","year":"2023","unstructured":"Jiang W, Yang X, Shi K, et al. MAD2 activates IGF1R\/PI3K\/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44\/LIMA1 complex [J]. Oncogene. 2023;42(45):3344\u201357.","journal-title":"Oncogene"},{"key":"9959_CR13","doi-asserted-by":"crossref","unstructured":"Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology, 2019, 156(2).","DOI":"10.1053\/j.gastro.2018.08.065"},{"issue":"7","key":"9959_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, et al. The Critical Role of RNA m6A Methylation in Cancer. Cancer Res. 2019a;79(7):1285\u201392.","journal-title":"Cancer Res"},{"issue":"7","key":"9959_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T. The Critical Role of RNA m6A Methylation in Cancer. Cancer Res. 2019b;79(7):1285\u201392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2965.","journal-title":"Cancer Res"},{"key":"9959_CR16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s41556-022-00994-w","volume":"24","author":"TD Larionova","year":"2022","unstructured":"Larionova TD, Bastola S, Aksinina TE, Anufrieva KS, Wang J, Shender VO, Andreev DE, Kovalenko TF, Arapidi GP, Shnaider PV, et al. Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells. Nat Cell Biol. 2022;24:1541\u201357. https:\/\/doi.org\/10.1038\/s41556-022-00994-w.","journal-title":"Nat Cell Biol"},{"issue":"19","key":"9959_CR17","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1111\/febs.15017","volume":"286","author":"N Li","year":"2019","unstructured":"Li N, Lu N, Xie C. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue. FEBS J. 2019;286(19):3745\u201356.","journal-title":"FEBS J"},{"key":"9959_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41419-023-05556-y","volume":"14","author":"H Li","year":"2023","unstructured":"Li H, Jiang Y, Hu J, Xu J, Chen L, Zhang G, Zhao J, Zong S, Guo Z, Li X, et al. The U2AF65\/circNCAPG\/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-beta pathway. Cell Death Dis. 2023b;14:23. https:\/\/doi.org\/10.1038\/s41419-023-05556-y.","journal-title":"Cell Death Dis"},{"key":"9959_CR19","doi-asserted-by":"crossref","unstructured":"Li D, Neo SP, Gunaratne J et al. EPLIN-\u03b2 is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration. J Cell Sci. 2023, 136(12).","DOI":"10.1242\/jcs.260427"},{"issue":"4","key":"9959_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3350\/cmh.2020.0178","volume":"26","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang X, Yang Y. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma. Clin Mol Hepatol. 2020;26(4):742\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"9959_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-023-05777-1","volume":"14","author":"D Liu","year":"2023","unstructured":"Liu D, Li Q, Zang Y, et al. USP1 modulates hepatocellular carcinoma progression via the Hippo\/TAZ axis. Cell Death Dis. 2023;14(4):264.","journal-title":"Cell Death Dis"},{"key":"9959_CR22","doi-asserted-by":"crossref","unstructured":"Liu Y-C, Yeh C-T, Lin K-H. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cells, 2020;9(6).","DOI":"10.3390\/cells9061331"},{"issue":"1","key":"9959_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"9959_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13045-021-01204-0","volume":"14","author":"S Lu","year":"2021","unstructured":"Lu S, Han L, Hu X, et al. N6-methyladenosine reader IMP2 stabilizes the ZFAS1\/OLA1 axis and activates the Warburg effect: implication in colorectal cancer. J Hematol Oncol. 2021;14(1):188.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"9959_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-020-0845-z","volume":"13","author":"X-L Ma","year":"2020","unstructured":"Ma X-L, Hu B, Tang W-G, et al. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma. J Hematol Oncol. 2020;13(1):11.","journal-title":"J Hematol Oncol"},{"key":"9959_CR26","doi-asserted-by":"publisher","first-page":"117955492211094","DOI":"10.1177\/11795549221109493","volume":"16","author":"W Ma","year":"2022","unstructured":"Ma W, Liao Y, Gao Z, et al. Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Clin Med Insights Oncol. 2022;16:11795549221109492.","journal-title":"Clin Med Insights Oncol"},{"key":"9959_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2016.12.034","volume":"390","author":"T Ohashi","year":"2017","unstructured":"Ohashi T, Idogawa M, Sasaki Y, et al. p53 mediates the suppression of cancer cell invasion by inducing LIMA1\/EPLIN. Cancer Lett. 2017;390:58\u201366.","journal-title":"Cancer Lett"},{"key":"9959_CR28","doi-asserted-by":"publisher","first-page":"674919","DOI":"10.3389\/fcell.2021.674919","volume":"9","author":"F Pan","year":"2021","unstructured":"Pan F, Lin X-R, Hao L-P, et al. The Role of RNA Methyltransferase METTL3 in Hepatocellular Carcinoma: Results and Perspectives. Front Cell Dev Biol. 2021;9:674919.","journal-title":"Front Cell Dev Biol."},{"key":"9959_CR29","doi-asserted-by":"publisher","unstructured":"Pan F, Lin XR, Hao LP, Chu XY, Wan HJ, Wang R. The Role of RNA Methyltransferase METTL3 in Hepatocellular Carcinoma: Results and Perspectives.\u00a0Front Cell Dev Biol. 2021;9:674919. Published 2021 May 11. https:\/\/doi.org\/10.3389\/fcell.2021.674919","DOI":"10.3389\/fcell.2021.674919"},{"key":"9959_CR30","doi-asserted-by":"crossref","unstructured":"Qi Y, Wang H, Zhang Q, et al. CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated \u03b2-Catenin Pathway. Cells. 2022;11(23).","DOI":"10.3390\/cells11233857"},{"issue":"3","key":"9959_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"9959_CR32","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of \u03b2-catenin. EMBO J. 2012;31(12):2714\u201336.","journal-title":"EMBO J"},{"issue":"11","key":"9959_CR33","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23(11):1369\u201376.","journal-title":"Nat Med"},{"key":"9959_CR34","doi-asserted-by":"publisher","first-page":"1115943","DOI":"10.3389\/fonc.2023.1115943","volume":"13","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang C, Song H, et al. Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers. Front Oncol. 2023a;13:1115943.","journal-title":"Front Oncol"},{"key":"9959_CR35","doi-asserted-by":"publisher","first-page":"216122","DOI":"10.1016\/j.canlet.2023.216122","volume":"559","author":"L Wang","year":"2023","unstructured":"Wang L, Yang Q, Zhou Q, et al. METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma. Cancer Lett. 2023b;559:216122.","journal-title":"Cancer Lett"},{"key":"9959_CR36","doi-asserted-by":"publisher","unstructured":"Wang W, Shao F, Yang X, et al. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding [published correction appears in Nat Commun. 2021 Jul 20;12(1):4529. https:\/\/doi.org\/10.1038\/s41467-021-24860-9].\u00a0Nat Commun. 2021;12(1):3803. Published 2021 Jun 21. https:\/\/doi.org\/10.1038\/s41467-021-23501-5","DOI":"10.1038\/s41467-021-24860-9 10.1038\/s41467-021-23501-5"},{"key":"9959_CR37","doi-asserted-by":"publisher","first-page":"m3544","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371:m3544.","journal-title":"BMJ"},{"issue":"1","key":"9959_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F, et al. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.","journal-title":"Signal Transduct Target Ther"},{"issue":"50","key":"9959_CR39","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1038\/onc.2011.199","volume":"30","author":"S Zhang","year":"2011","unstructured":"Zhang S, Wang X, Osunkoya AO, et al. EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene. 2011;30(50):4941\u201352.","journal-title":"Oncogene"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-024-09959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-024-09959-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-024-09959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:02:28Z","timestamp":1734739348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-024-09959-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9959"],"URL":"https:\/\/doi.org\/10.1007\/s10565-024-09959-1","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of Shanxi Bethune Hospital and conducted by the National Institutes of Health (NIH) in accordance with the Guide for the Care and Use of Laboratory Animals. This study was approved by the Ethics Committee of Shanxi Bethune Hospital and followed the Clinical Research Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors in this paper consent to publication of the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}